It will therefore be important to investigate whether ectopic overexpression of DTX3L xenograft tumors (alone or simultaneously in combination with ARTD9 and/or STAT1) may positively or negatively affect chemoresistance, enhanced growth and/or metastasis of HR-DLBCL tumors in vivo. This evidence concerns the gene STAT1 and diffuse large B-cell lymphoma.